“Efficacy and Safety of Topical Tacrolimus (0.03%) in the Treatment Localized Vitiligo”, Med. Today, vol. 29, no. 1, pp. 1–5, Aug. 2017, doi: 10.3329/medtoday.v29i1.33850.